Treatment With Combination of Lenalidomide and Rituximab Achieves Durable Responses in a Long Term Follow Up of Patients With Indolent Non-Hodgkin's Lymphoma

Hematological Oncology- United Kingdom

doi 10.1002/hon.2438_79

Full Text

Abstract

Available in

Date

June 1, 2017

Authors

Publisher

Wiley

Related search

A Phase Ii Trial of Rituximab/Lenalidomide Followed by Lenalidomide Maintenance in Untreated and Relapsed Indolent Lymphoma: Long Term Follow Up and Correlative Analysis

Hematological Oncology

English

Characteristics and Management of Rash Following Lenalidomide and Rituximab in Patients With Untreated Indolent Non-Hodgkin Lymphoma

Haematologica

Hematology

2015

English

A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Follicular Non-Hodgkin Lymphoma

Leukemia and Lymphoma

English

Long-Term Follow-Up of Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Receiving Purged Autografts After Induction Failure

Bone Marrow Transplantation

Transplantation

Hematology

2009

English

Long-Term Follow-Up After Localized Radiotherapy in Patients With Transformed B-Cell Lymphoma Treated With Rituximab-Containing Chemotherapy

Hematological Oncology

English

Chronic Hepatitis E in Patients With Indolent Lymphoma After Treatment With Rituximab and Bendamustine

English

Clinical Stage 1 Non-Hodgkin's Lymphoma: Long-Term Follow-Up of Patients Treated by the British National Lymphoma Investigation With Radiotherapy Alone as Initial Therapy

British Journal of Cancer

Cancer Research

Oncology

1994

English

A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Indolent Non-Hodgkin's Lymphoma

British Journal of Haematology

Hematology

2015

English

A Long-Term Follow-Up of 33 Patients With Non-Hodgkin's Lymphoma Who Received the BEAM High-Dose Intensification Regimen With Cytokine Support Only and No Transplant

English

Amanote Research

Treatment With Combination of Lenalidomide and Rituximab Achieves Durable Responses in a Long Term Follow Up of Patients With Indolent Non-Hodgkin's Lymphoma

Hematological Oncology- United Kingdom

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

A Phase Ii Trial of Rituximab/Lenalidomide Followed by Lenalidomide Maintenance in Untreated and Relapsed Indolent Lymphoma: Long Term Follow Up and Correlative Analysis

Characteristics and Management of Rash Following Lenalidomide and Rituximab in Patients With Untreated Indolent Non-Hodgkin Lymphoma

A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Follicular Non-Hodgkin Lymphoma

Long-Term Follow-Up of Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Receiving Purged Autografts After Induction Failure

Long-Term Follow-Up After Localized Radiotherapy in Patients With Transformed B-Cell Lymphoma Treated With Rituximab-Containing Chemotherapy

Chronic Hepatitis E in Patients With Indolent Lymphoma After Treatment With Rituximab and Bendamustine

Clinical Stage 1 Non-Hodgkin's Lymphoma: Long-Term Follow-Up of Patients Treated by the British National Lymphoma Investigation With Radiotherapy Alone as Initial Therapy

A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Indolent Non-Hodgkin's Lymphoma

A Long-Term Follow-Up of 33 Patients With Non-Hodgkin's Lymphoma Who Received the BEAM High-Dose Intensification Regimen With Cytokine Support Only and No Transplant